Considering the pivotal role of STAT3 and Akt in anti-apoptotic machinery [23, 25, 30, 31], our study answers, at least partly, why certain types of lung cancer cells are resistant to gefitinib-induced cell death. Here, STAT3 is linked to lung carcinoma.